creating a
healthier future
Vanda Pinto
Project Manager

Vanda obtained her PhD in Biomedicine at the University of Porto, Portugal. She did her postdoctoral research first at the Bristol Medical School, UK, studying the insulin-PI3K/Akt signaling pathway in diabetic nephropathy, then at IPATIMUP where her focus was on aberrant glycosylation in lupus nephritis and inflammatory bowel disease. 

Currently, Vanda is a Project Manager at the Immunology, Cancer & Glycomedicine group where she oversees the GlycanTrigger project, funded by Horizon Europe. In addition to her role on GlycanTrigger, Vanda is also involved in the management of the ERC Synergy-funded project, GlycanSwitch. With her expertise in glycosylation and immunology research, Vanda is dedicated to advancing the field through the successful execution of these important projects.